ArticleFrontiers in medicine2026
Comparison of early clinical and optical quality-related outcomes after SMILE using VisuMax 800 versus VisuMax 500 for myopia and low-to-moderate astigmatism in a Chinese population: a single-center retrospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Vector outcomes after SMILE pro with the VISUMAX 800 for high versus moderate-to-low astigmatism: a contralateral eye comparison.Frontiers in medicine · 2026Article
- Femtosecond laser-assisted LASIK in the SMILE era: a mini review of patient-centered procedure selection.Frontiers in medicine · 2026Review
- Association of Treatment Decentration with Early Outcomes Following SMILE Pro: A Secondary Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare early clinical outcomes, centration accuracy, and optical quality-related parameters after small incision lenticule extraction (SMILE) performed using the VisuMax 800 and VisuMax 500 platforms in a Chinese population with myopia and low-to-moderate astigmatism. Methods: This retrospective, single-center comparative study included 200 patients (200 eyes) who underwent SMILE between May and August 2025. Patients were grouped according to the laser platform used in routine clinical practice: the SMILE group (VisuMax 500, Results: No significant between-group differences were observed in postoperative uncorrected or corrected distance visual acuity, safety index, or efficacy index (all Conclusion: At 3 months postoperatively, both VisuMax 500-and VisuMax 800-based SMILE showed favorable safety and efficacy for the correction of myopia and low-to-moderate astigmatism. Compared with conventional SMILE (VisuMax 500), SMILE Pro (VisuMax 800) was associated with shorter laser scanning time, lower optical zone decentration, lower postoperative vertical coma, and more favorable astigmatic vector outcomes. These findings represent early postoperative results and should be interpreted cautiously. Further prospective, multicenter studies with larger sample sizes and longer follow-up are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.